Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00090038
What this trial is testing

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 168
Early research (Phase 1)Study completedNCT01041508
What this trial is testing

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

Who this might be right for
Leukemia Lymphoblastic, AcuteAcute Myeloid LeukemiaNeoplasm Recurrent
Therapeutic Advances in Childhood Leukemia Consortium 18
Very early researchEnded earlyNCT03585725
What this trial is testing

A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

Who this might be right for
Follicular LymphomaMantle Cell Lymphoma
Weill Medical College of Cornell University 3
Not applicableNot Yet RecruitingNCT05298293
What this trial is testing

Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Weprom 160
Large-scale testing (Phase 3)Study completedNCT00877006
What this trial is testing

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
Teva Branded Pharmaceutical Products R&D, Inc. 447
Early research (Phase 1)Study completedNCT02187133
What this trial is testing

Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)UnknownNCT02710149
What this trial is testing

A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies

Who this might be right for
LeukemiaLymphoma
Southwest Hospital, China 45
Early research (Phase 1)Ended earlyNCT02924038
What this trial is testing

Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

Who this might be right for
GliomaMalignant GliomaAstrocytoma, Grade II+3 more
Nicholas Butowski 14
Very early researchLooking for participantsNCT07558538
What this trial is testing

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital 24
Post-approval studies (Phase 4)Looking for participantsNCT07094048
What this trial is testing

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Who this might be right for
Multiple Myeloma RefractoryRelapsed Multiple Myeloma
CHU de Quebec-Universite Laval 80
Early research (Phase 1)Study completedNCT00352443
What this trial is testing

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 66
Early research (Phase 1)Study completedNCT04626843
What this trial is testing

Intermittent Fasting and CLL/SLL

Who this might be right for
NeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic+3 more
Eleah Stringer 15
Early research (Phase 1)Looking for participantsNCT06859008
What this trial is testing

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecurrent Diffuse Large B-Cell Lymphoma+16 more
City of Hope Medical Center
Not applicableUnknownNCT05130099
What this trial is testing

A Complex Intervention for Chronically Fatigued Lymphoma Survivors

Who this might be right for
Chronic Fatigue Syndrome
Oslo University Hospital 150
Not applicableStudy completedNCT05091333
What this trial is testing

FASENRA Regulatory Postmarketing Surveillance in Korea

Who this might be right for
Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)
AstraZeneca 51
Testing effectiveness (Phase 2)UnknownNCT05322733
What this trial is testing

Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University 25
Early research (Phase 1)Study completedNCT02939183
What this trial is testing

Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Amgen 61
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Testing effectiveness (Phase 2)Ended earlyNCT01510756
What this trial is testing

Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 4
Early research (Phase 1)Looking for participantsNCT06441331
What this trial is testing

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Who this might be right for
Somatostatin Receptor PositiveNETsLymphoma+5 more
ITM Solucin GmbH 20
Next Page
37